Submitted By: Charles Mayo / University of Michigan | |
---|---|
Data Element Information | |
Use Case Description(s) | |
Use Case Description | Categorization of disease response to treatment outcome. All instances record the Patient Age and/or the Date at the time of assigning the Patient Treatment Outcome. This information is vital to understanding effectiveness of treatment approaches and for public heath policy guidance |
Estimate the breadth of applicability of the use case(s) for this data element | All cancer care providers |
Healthcare Aims |
|
Maturity of Use and Technical Specifications for Data Element | |
Applicable Standard(s) | N/A |
Additional Specifications | N/A |
Current Use | In limited use in production environments |
Supporting Artifacts |
Snomed CT SCTID- 716618008; NCI Thesarus NCITC- C18919 ; NCIMT- C1518681} |
Extent of exchange | N/A |
Potential Challenges | |
Restrictions on Standardization (e.g. proprietary code) | No restrictions |
Restrictions on Use (e.g. licensing, user fees) | None |
Privacy and Security Concerns | None |
Estimate of Overall Burden | Minor effort to implement collection with positive impact for providers, referrals, and institutions |
Data Element |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cancer Treatment Evaluation Basis of Disease Status
Description
What measures were used in the determination of the disease status. Physical exam PSA Plain film radiographs Bone scan Magnetic Resonance Imaging Computed Tomograph Biochemical marker (PSA) PET-CT (PSMA) PET-CT (F-18 fluciclovine) PET-CT (C-11 choline) In OORO for each instance record of a Cancer Patient Treatment Outcome, multiple values of Evaluation Basis of Disease Status can be selected e.g. PSA, MRI |
||||||||||
|
Comment